Blueprint for a Catalan Apheresis Database Initiative: The Catalan Apheresis Therapeutics Network and Its Role in Supporting Health Administration Planning.
Joan Cid, Eva Rodríguez, Sandra Ortega, Anna M Garcia, Jordi Comas, Paola Charry, Miquel Lozano, Rosa Ramos
{"title":"Blueprint for a Catalan Apheresis Database Initiative: The Catalan Apheresis Therapeutics Network and Its Role in Supporting Health Administration Planning.","authors":"Joan Cid, Eva Rodríguez, Sandra Ortega, Anna M Garcia, Jordi Comas, Paola Charry, Miquel Lozano, Rosa Ramos","doi":"10.1159/000545202","DOIUrl":null,"url":null,"abstract":"<p><p>The Therapeutic Apheresis Database in the Catalan Region (AfTerCat) was developed to consolidate and standardize data collection for therapeutic apheresis procedures across public and private institutions in Catalonia. Covering procedures performed from 2019 to 2023 in 21 apheresis units, the registry captures data on plasma treatments, cell therapies, and cytapheresis procedures, with over 26,000 recorded entries. Variations in workload across public and private institutions were noted, influencing resource needs and operational costs. By streamlining manual data collection and planning future automation, the AfTerCat registry aims to provide crucial insights for healthcare administrators in optimizing resource allocation, managing procedure costs, and supporting evidence-based policy decisions. The registry's integration into the Organització Catalana de Trasplantaments (OCATT) digital transformation initiative highlights its potential to impact health policy through improved data centralization and real-time analysis. This project serves as a foundational step toward efficient health system planning and cost management in the growing field of therapeutic apheresis.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-8"},"PeriodicalIF":2.2000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12060802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545202","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The Therapeutic Apheresis Database in the Catalan Region (AfTerCat) was developed to consolidate and standardize data collection for therapeutic apheresis procedures across public and private institutions in Catalonia. Covering procedures performed from 2019 to 2023 in 21 apheresis units, the registry captures data on plasma treatments, cell therapies, and cytapheresis procedures, with over 26,000 recorded entries. Variations in workload across public and private institutions were noted, influencing resource needs and operational costs. By streamlining manual data collection and planning future automation, the AfTerCat registry aims to provide crucial insights for healthcare administrators in optimizing resource allocation, managing procedure costs, and supporting evidence-based policy decisions. The registry's integration into the Organització Catalana de Trasplantaments (OCATT) digital transformation initiative highlights its potential to impact health policy through improved data centralization and real-time analysis. This project serves as a foundational step toward efficient health system planning and cost management in the growing field of therapeutic apheresis.
治疗单采数据库(AfTerCat)的开发是为了巩固和标准化加泰罗尼亚公共和私人机构治疗单采程序的数据收集。它涵盖了2019年至2023年间在21个单采单位进行的手术,有26,000多个条目,包括血浆治疗、细胞治疗和细胞分离。注意到公共和私营机构之间工作量的差异,这影响到资源需求和业务成本。通过简化手动数据收集和规划未来的自动化,AfTerCat注册中心旨在为医疗保健管理人员在优化资源分配、管理流程成本和支持基于证据的政策决策方面提供重要见解。该登记处与Organització Catalana de Trasplantaments (OCATT)数字化转型计划的整合,突显了其通过改进数据集中化和实时分析影响卫生政策的潜力。该项目是在日益增长的治疗性血液分离领域实现高效卫生系统规划和成本管理的基础步骤。
期刊介绍:
Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.